Motus GI Holdings initiated with an Overweight at Piper Jaffray

Piper Jaffray analyst Matt O’Brien started Motus GI Holdings with an Overweight rating and $7 price target. The stock closed Friday up 4c to $4.98. The company’s technology to improve colon preparation addresses a multi-billion dollar market opportunity, O’Brien tells investors in a Sunday night research note. He notes the technology has received regulatory approval in both the U.S. and Europe, which he feels “de-risks that component of the story.” The analyst believes the device will find “strong traction among clinicians resulting in sizable revenue growth.”